Cargando…
Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population
SIMPLE SUMMARY: Trastuzumab administered as a (neo)adjuvant therapy in radically treated Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer patients improves overall survival. This study aimed to assess if factors commonly thought to play a role as biomarkers of trastuzumab-induc...
Autores principales: | Grela-Wojewoda, Aleksandra, Püsküllüoğlu, Mirosława, Sas-Korczyńska, Beata, Zemełka, Tomasz, Pacholczak-Madej, Renata, Wysocki, Wojciech M., Wojewoda, Tomasz, Adamczyk, Agnieszka, Lompart, Joanna, Korman, Michał, Mucha-Małecka, Anna, Ziobro, Marek, Konduracka, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313458/ https://www.ncbi.nlm.nih.gov/pubmed/35884413 http://dx.doi.org/10.3390/cancers14143353 |
Ejemplares similares
-
Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer
por: Grela-Wojewoda, Aleksandra, et al.
Publicado: (2022) -
Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Systematic Review
por: Püsküllüoğlu, Mirosława, et al.
Publicado: (2022) -
Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience
por: Pacholczak-Madej, Renata, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitor Related Rheumatological Complications: Cooperation between Rheumatologists and Oncologists
por: Pacholczak-Madej, Renata, et al.
Publicado: (2023) -
Shifting Treatment Paradigms: Improvements in HR-Positive, HER-2- Negative Breast Cancer Care in Poland from a Clinical Perspective
por: Ziobro, Marek, et al.
Publicado: (2023)